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Socioeconomic inequalities in health have received significant attention globally because of 
the well-known association between wealth and health. A lot of studies show that poor people 
are more prone to sickness than their counterparts. Immunisation has been a key antidote to 
avert deaths for children under the age of 5. This study represents an initial attempt to assess 
specific variables that contribute to socioeconomic inequalities in immunisation coverage in 
Zimbabwe. 
Data were obtained from the 2015 Zimbabwe Demographic Health Survey, a nationally 
representative survey. Immunisation coverage was measured using four categories: full 
immunisation (a child who will have received 10 doses of vaccines), partial immunisation (a 
child who will have received at least one but not all vaccines), no immunisation (a child who 
will not have received any immunisation dose from birth) and immunisation intensity (a 
proportion of doses received to total doses that they should have received). Inequalities in 
immunisation coverage in Zimbabwe were assessed using concentration curves and indices. A 
positive (negative) concentration index indicates immunisation coverage concentrated among 
the rich (poor). The concentration index was decomposed to identify how different variables 
contribute to the socioeconomic inequality in immunisation coverage in Zimbabwe. 
Results indicate that immunisation intensity and full immunisation concentration indices were 
(0.0154) and (0.0250) respectively, indicating that children from lower socio-economic status 
are less likely to receive all doses of vaccines. No immunisation and partial immunisation 
concentration indices were (-0.0778) and (-0.0878) indicating that children from higher socio-
economic status are more likely to have their children immunised opposed to their poor 
counterparts. The main contributors to socioeconomic inequality in immunisation coverage are 
the mother’s education, socioeconomic status and place of residence (rural/urban and 
province). 
While immunisation services are free of charge in the public health sector in Zimbabwe, 
coverage rates are higher among the wealthy, which shows that there may be barriers to 
utilising these services that may not be the direct cost of vaccination. There have to be measures 
by the government to reach people in areas that are not easily accessible. Also, more needs to 
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Globally, progress has been made to reduce under 5 mortality rates but there are still disparities 
between countries and regions (Raza et al, 2018). In 1974 the World Health Organization 
(WHO) introduced the Expanded Program on Immunisation (EPI) to avert childhood diseases 
such as measles, tuberculosis, pertussis (whooping cough), diphtheria, tetanus and 
poliomyelitis (Chang et al, 2018). According to Global Alliance for Vaccines and 
Immunisation child Immunisation is one of the key interventions that has made a significant 
impact in averting deaths of children under the age of 5 in different countries, and it is also 
considered a cost-effective intervention for both low and middle-income countries (Ataguba et 
al, 2016). 
 
An estimated 6.3 million children under the age of 15 years died in 2017, 5.4 million of those 
were under the age of 5. An estimated 19.9 million children globally did not receive the 3 doses 
of DPT (WHO, 2017). Although the total number of under-5 deaths worldwide declined from 
12.6 million in 1990 to 5.4 million in 2017 (WHO, 2017), sub-Saharan Africa is still the region 
with the highest mortality rates with children being 14 times more likely to die under the age 
of 5 compared to the rest of Africa (United Nations, 2015). 
 
Child mortality is an indicator used to assess how well a country’s health system is performing 
(Reidpath & Allotey, 2003). During 2017, about 85% of infants worldwide (116.2 million 
infants) are fully immunised, receiving the 3 doses of diphtheria-tetanus-pertussis (DTP1-3) 
vaccine that protect them against infectious diseases that can cause severe illness and disability 
(UNICEF, 2018). 
 
Low and middle-income countries, compared to high-income countries, have lower 
immunisation coverage rates with significant disparities between the rich and the poor, even 
though immunisations services are usually free (UNICEF, 2018). It is crucial to understand the 
socio-economic disparities between different population groups within and between countries. 
The Alma Ata declaration of 1978 advocated the need to bridge the gap between the rich and 
poor in accessing health services (Gillam, 2008). Addressing inequalities in health has been 
widely recognised as a crucial developmental goal in improving the health system’s 
performance and economic growth (Regidor, 2004a). Overall, analysing health inequalities is 
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important because, in broader economic terms, health economists acknowledge the relationship 
between improved population health and economic growth (Lauridsen & Pradhan, 2011). 
 
Problem statement  
 
The population of Zimbabwe was estimated at 16.7 million people in 2018.  In 2017, the infant 
mortality rate was estimated at 36 deaths per 1,000 live births and the under-5 mortality rate 
was estimated at 50 deaths per 1,000 live births (UNICEF, 2018). The leading cause of child 
mortality is HIV and AIDS, with a prevalence of 13.3%  and contributing to 21% of deaths 
(WHO, 2018). Other major contributors to under-5 mortality are pneumonia, measles, 
diarrhoea, malnutrition and malaria (WHO, 2008). Figure 1 represents the Zimbabwean 
government’s immunisation schedules, which are in line with that of the WHO. 
 
Figure 1: Immunisation schedule for children under 1 year in Zimbabwe  
Source: Ministry of Health and Child Care, 2017 
 
Zimbabwe is a country in the sub-Saharan Africa region that adopted the EPI in 1982 and 
attained Universal Child Immunisation in 1990 with a considerable reduction in morbidity and 
mortality from vaccine-preventable diseases and longer inter-epidemic periods of measles up 
to 2008 (Mukungwa, 2015). Poor economic performance has, to a large extent, affected 
immunisation coverage in Zimbabwe, causing it to decline (Sibanda & Doctor, 2013). In 2017 
immunisation coverage was 89%, which is 1% short of reaching the WHO’s target of 90% 
(UNICEF, 2018). The region has countries like Nigeria, with about 39% (3 980 000) of children 
First contact at birth – BCG 
Second contact at 6 weeks – OPV 1, DTP-HepB-Hib1 (Pentavalent), PCV 1, Rotavirus 1 
Third contact at 10 weeks – OPV 2, DTP-Hep B-Hib 2 (Pentavalent), PCV 2, Rotavirus 2 
Fourth contact e at 14 weeks – OPV 3, DTP-Hep B-Hib 3 (Pentavalent), PCV 3, IPV  




unvaccinated (UNICEF, 2018 ). Ethiopia is another country with a large number of 
unvaccinated children pegged at  23% (853000) (UNICEF, 2018). 
 
According to Kidia (2018), the government of Zimbabwe allocated 7.7% of the national budget 
to health, which is a relatively small amount. Zimbabwe, like many other developing countries, 
is heavily reliant on donor funding and faces challenges which include weak health systems 
(Olapade-Olaopa et al, 2016).  The country also faces epidemics which continue to strain the 
health system. These include cholera and typhoid outbreaks that highlight the country’s poor 
infrastructure, such as cracked sewer pipes (Mukandavire et al, 2011).  
 
The Zimbabwean government in 2017 removed user fees for vulnerable groups (expecting 
mothers, children under the age of 5 and elderly citizens over 65 years) as a pro-poor health 
policy to increase the use of health services by less economically advantaged (Meessen et al, 
2011).  Removing user fees’ intent was to improve health outcomes and offer some financial 
protection for these groups (James et al, 2006).  On the other hand, this policy has put a strain 
on the workload on health staff, with a doctor-patient ratio of 1:250,000 (Kidia, 2018). The 
strain put on health staff also includes drug stock-outs when there is high demand of health 
services including immunisations, and this sometimes frustrates them and affects service 
delivery which in turn causes a ripple effect to patients not accessing health services (Gilson & 
McIntyre, 2005).  
 
When comparing child mortality across socioeconomic groups in the country, the poor are the 
most affected, conforming to the concept of social gradient that is usually present in developing 
countries (Hämmig & Bauer, 2013). Social gradient refers to inequalities in populations related 
to the socioeconomic status where morbidity and mortality rise steadily with gradually 
decreasing social or socioeconomic status (Hämmig & Bauer, 2013). Vaccines are free, but 
access barriers usually affect service utilisation. Literature suggests that there is a high 
immunisation coverage, but the poor still face access barriers in accessing health services such 
a long walking distance to clinics, poor service delivery and in most cases a shortage of staff 
as has been mentioned particularly in rural areas (Ray & Masuka, 2017). 
 
Religious beliefs in the country contribute to some of the hesitancy towards immunisation that 
affects coverage (Oleribe et al, 2017). The apostolic faith in Zimbabwe which had a following 
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of 4 million people in 2016 does not believe in getting their children immunised which works 
against the government’s efforts to increase coverage of immunisation in the country (Gerede 
et al, 2017).  With large numbers of children not immunised it could increase the chance of 
other children being infected with vaccine-preventable diseases (Gerede et al, 2017). 
 
Zimbabwe, a low-income country with great economic potential (Mukungwa, 2015), has an 
abundance of natural resources that could help the country generate income but is poorly 
governed (Cain, 2016). This poor governance affects resource allocation, which affects service 
provision and causes the under-utilisation of state resources. Corruption is one of the major 
forms of poor governance that the government faces (Mukungwa, 2015).  
 
Rationale of the study  
 
The government of Zimbabwe acknowledges that the use of research evidence in informed 
decision making is essential to improve health outcomes (Cairney & Oliver, 2017). No known 
study in Zimbabwe has attempted to decompose health inequalities, especially in immunisation 
coverage, a significant child health indicator.  This makes the study an important study.   
 
Economically disadvantaged households in most cases get caught in a poverty trap when their 
children fall ill, which can potentially be evaded if it is a vaccine-preventable disease (Carter 
& Barrett, 2006). These inequalities are also obstacles to the human rights of people having 
access to health services and needs rectification (London, 2008).  
 
The result of this study is to make policymakers aware of inequalities that the population is 
facing so that they can address the issues that can allow all social groups to have an equal 
chance to have good health (Lauridsen & Pradhan, 2011). The results of the study could help 
inform policymakers on the better allocation of resources in such a way that all socioeconomic 
groups are adequately reached. Furthermore, the ultimate result is for immunisation coverage 












• To estimate socioeconomic inequality in child immunisation coverage in Zimbabwe  
• To explain the factors that contribute to the socioeconomic inequalities in child 
immunisation in Zimbabwe. 
 
BRIEF LITERATURE REVIEW 
 
Theories of health inequality 
 
Theories of health inequalities are important because a successful identification of causes of 
any problem is crucial to solving the problem (McCartney et al, 2013). The Black report, a 
document published in 1980 in the United Kingdom, suggested that there were large 
differences in mortality and morbidity that favoured higher social classes and were not being 
redressed by social services (Smith et al, 1990). The document presented four types of 
explanations of how health inequalities arise: artefacts, selection, behavioural/ cultural and 
materialistic. 
 
Artefacts theory is more relevant to the measurement of social class. It urges us to look 
critically at how health and social class are measured and suggests that the apparent 
relationship between the two variables may be inherent in the measures themselves (Blane, 
1985). The health of a population can variously be measured by the rates of morbidity and 
mortality, and these are seen as indicators. The Black report was unable to explain this theory 
but showed an important point about the importance of taking note of how social classes 
impact, to a greater extent, the level and distribution of health (Smith et al, 1990).  
 
Selection theory sees an individual's health as having an important influence on their chances 
of social mobility. Those in better health than their class peers, it is argued, are more likely to 
be upwardly mobile, and those in worse health downwardly mobile. This explanation, 
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therefore, accepts a causal connection between health and social class and sees social class as 
the dependent variable (Blane, 1985). 
 
Behavioural/cultural theory suggests that differences in behaviours adopted by people such as 
smoking, taking drugs, alcohol consumption, diet and physical activity cause health 
inequalities (Arcaya et al, 2015). Differences in health behaviour are a consequence of 
disadvantage, and that unhealthy behaviour may be more culturally acceptable amongst lower 
socio-economic groups (Skalická et al, 2009). For example, studies have found associations 
between the low socioeconomic position (SEP) and higher prevalence of biomedical risk 
factors such as obesity, high blood pressure, glucose intolerance etc. (Skalická et al, 2009). 
 
The materialistic theory is the most favoured explanation and notes that social class differences 
in health may be seen as an inevitable consequence of the competitive accumulation of capital 
(Smith et al, 1990). At the intermediate level, health may be linked to factors such as income, 
poverty and access to education etc. Some studies have found that a wide range of diseases are 
associated with manual workers exposed to dust and chemicals and noise, and these are usually 




There are several ways to measure health inequality such as the Gini index, pseudo-Lorenz 
curve, the index of dissimilarity, slope index of inequality but the most commonly used method 
is the concentration index. 
 
The Gini index is based on the Lorenz curve which plots the cumulative distribution of 
individuals (on the x-axis), against the cumulative proportion of the health outcome in the 
population (on the y-axis). The Gini index is derived from the Lorenz curve as two times the 
area between the Lorenz curve and the line of equality  (Regidor, 2004a). The index is used to 
measure economic inequality and ranges from 0, which represents perfect equality to 1, which 
represents perfect inequality. If health is equally distributed, the Lorenz curve coincides with 
the diagonal. The further the Lorenz curve is from the diagonal, the greater the inequality 




The pseudo-Lorenz curve uses groups rather than individual data, unlike the Lorenz curve. 
Groups are occupational classes and not health classes which are ranked by mortality ranked 
from lowest mortality class to highest mortality (Wagstaff et al, 1991a). The pseudo-Lorenz 
curve like the true Lorenz curve fails to reflect the relationship between inequalities in health 
and SES (Sibanda & Doctor, 2013; Wagstaff et al, 1991a). 
 
The index of dissimilarity represents the proportion of total health that would need to be 
transferred from the healthy to those whose health is below average to achieve a situation of 
total equity (Regidor, 2004a). It assumes that socio-economic inequalities are derived from the 
inefficient distribution of resources (Sibanda & Doctor, 2013). The weakness of this method is 
that it is insensitive to socioeconomic dimension to inequalities in health, meaning it does not 
pay particular attention to where high morbidity or mortality are located in any socioeconomic 
group (Sibanda & Doctor, 2013).  The slope index of inequality is a linear regression coefficient 
that shows the relationship between the level of health in each socioeconomic group and the 
ranking of each socioeconomic category on the social scale (Regidor, 2004b).  
 
The concentration index is based on the concentration curve. Here, the x-axis represents the 
cumulative proportion of individuals by socioeconomic category ranking them from those with 
the lowest level up to those with the highest socioeconomic level while the y-axis represents 
the cumulative proportion of health in these individuals (Regidor, 2004b). The concentration 
index ranges from -1 to +1. Like the Lorenz curve, if the concentration curve coincides with 
the diagonal (i.e. the line of equality), all individuals have the same health (Erreygers, 2009). 
When the curve lies above the line of equality, the concentration index will be negative and 
health is concentrated more towards the poor, and when it is underneath the line of equity, the 
concentration index will be positive and health is concentrated more on the rich (O'Donnell et 
al, 2016). It includes all individuals in a population and is sensitive to changes in the 
distribution of the population across different socioeconomic categories (Regidor, 2004b; 
Zhang & Wang, 2007). 
 
Empirical Review  
 
There is consistent evidence globally that individuals with socioeconomic disadvantage suffer 
a more substantial burden of illness and have higher mortality rates than their better-off 
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counterparts (Gwatkin, 2000a). These socioeconomic inequalities in health are a major 
challenge for health policy, not only because most of these inequalities can be considered 
unfair, but also because a reduction in the burden of health problems in disadvantaged groups 
offers great potential for improving the average health status of the population as a whole 
(Shaw, 2005). 
 
Also, most studies agree that people in lower socio-economic spectrum utilise less health care 
services than those on a higher spectrum (Wagstaff & Van Doorslaer, 2000). Mortality and 
morbidity rates are inversely related to many correlates of socioeconomic status, which include 
income, education, social class and wealth (Deaton, 2002). The concept was documented in 
1820 in Paris by Rene Villerme, who compared poverty and mortality rates. Empirical evidence 
in developed countries suggests that an additional year of education, which is protective of 
health reduces mortality rates by about 8% (Deaton, 2002; Merten et al, 2015).  
 
Literature in low- and middle-income countries (LMIC) seeks to identify socioeconomic 
factors that affect immunisation but do not go further to decompose health inequality (Flatø & 
Zhang, 2016). Nigeria is the one country that had a study explaining the inequalities and the 
study reported that full immunisation coverage is to the advantage of the rich and partial and 
no immunisation leans more towards poor children (Ataguba et al, 2016). Factors such as 
mother’s literacy, region and location of residence, and socioeconomic status significantly 
explain disparities in immunisation (Ataguba et al, 2016).   
 
Results of a study in Zimbabwe showed that the region of residence was important because 
immunisation compliances differ by regions with Bulawayo and Mashonaland recording the 
highest immunisation rates (Mukungwa, 2015). Full vaccination also increased with the 
mother’s level of education. About 71% of children whose mothers had secondary education 
were fully vaccinated compared to 54% of children whose mothers only had primary education. 
Religion, media, distance to health facility all were moderately associated with full 
immunisation (Mukungwa, 2015). 
 
In Kenya and Kampala, studies showed that there were lower immunisation rates among 
children in urban areas, especially those that live in informal settlements and slums (Asuman 
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et al, 2018). These differences can arise because of development strategies and also depending 
I how rural and urban areas are defined (Asuman et al, 2018).  
 
The Zimbabwean literature on the topic is sparse, which is one of the reasons why this study is 
essential. The purpose of the study, therefore, is to fill a gap that is existing in explaining the 






Data for this paper was obtained from the Demographic and Health Survey (DHS) that was 
conducted in 2015 in Zimbabwe. Among other things, the DHS surveys usually provide 
detailed information on different modules such as fertility, family planning and mortality etc. 
The DHS is conducted as national surveys in more than 90 developing countries (Boulton et 
al, 2018). The surveys are conducted to gain more knowledge of current situations which help 
the government in policy and decision making.  
 
Study population  
 
The sample sizes for the DHS are contained in Table 1. 
 
Table 1: Zimbabwe DHS sampling statistics   
Country  Household sample 
size  
Females  Males  Phase 
Zimbabwe  11196 9955 8396 VII 
Source: DHS database 2015 
 
Households were surveyed and depending on whether they had children who were between the 
ages of 12 months to 5 years, they would then have the key indicator survey, of the child’s 
health on the mother/father or the caretaker, administered. The surveys took, on average, 18-
18 
 
20 months for data collection in the field. The survey file used will be the maternal and child 






Stata 15 software was used for data analysis. Four immunisation coverage variables will be 
generated– (a) fully immunised children (children aged 12-59 months that received all of the 
10 vaccinations- BCG, Rotavirus 1-2, DTP 1-3, PCV 1-3, OPV 1-3, IPV and MR), (b) partially 
immunised children (those that received at least 1 but not all the 10 doses, (c) children not 
immunised (those that did not receive any vaccine from birth). The last category was introduced 
because partial immunisation ranges from a child receiving 1-9 vaccines.  It measures the 
intensity of immunisation, defined as the proportion of vaccines received over the total number 
of vaccines that should be received.  
 
It is important to note that this paper uses 10 vaccines in the analysis as opposed to the 14 
shown in Box 1 above. 10 vaccines are used because the rotavirus was introduced in 2014, a 
year before the survey, which would not have given a good reflection of the number of children 
who received the dose. Specifically, rotavirus 1 and 2 were dropped. The Inactivated Polio 
Vaccine (IPV) was also introduced in 2019 which is an obvious exclusion. Measles and Rubella 
was a supplementary dose introduced in Zimbabwe in 2015 and may not be included in the 
mainstream vaccine doses or collected in the 2015 DHS data. After removing these 4 doses 
due to the reasons mentioned above, the remaining 10 doses were used to categorise children 
into different immunisation coverage indicators.  
The study will use concentration indices (CI) and curves to represent the magnitude of 
socioeconomic-related inequality in immunisation coverage (O'Donnell et al, 2016). As 
introduced under the methodological review, the concentration curves give rise to 
concentration indices, which are calculated as two times the area between the concentration 




Each immunisation variable will be indirectly standardised with age and sex as a way to reduce 
confounding effects.  
 
The blue concentration curve in Figure 2 shows a pro-poor distribution.  This is the case where 
the concentration index will be negative and more immunisation coverage is recorded among 
the poor. The red concentration curve shows a pro-rich distribution where the concentration 
index will be positive. The green concentration curve coincides with the line of equity.  
 
 
Figure 2: Concentration curve for health  
 
Source:(Phiri & Ataguba, 2014a)  
 
Although concentration curves show the extent of socio-economic inequality they do not 
explain factors that contribute to observed inequalities (Ataguba et al, 2016). Wagstaff 
proposed a straightforward way of decomposing the degree of inequality into contributions of 
explanatory factors  (Lauridsen & Pradhan, 2011). Wagstaff et al showed that the concentration 






C is equal is the concentration index concentration. Ck (𝑥𝑥k) is the concentration index (mean) 
of the kth contributing factor. βk is the OLS coefficient on the kth contributing factor obtained 
from a regression of the immunisation variable on the contributing factors whereas  GC𝜀𝜀 is the 
generalised concentration index for the error term (𝜀𝜀). The equation above is used to obtain the 





There will be minimal ethical consideration because the data are secondary. As a researcher, 
permission was granted by the DHS group to download the Zimbabwe DHS dataset. However, 




No cost is directly associated with the study.  The NRF supports my education at UCT. 
 
Dissemination of information to stakeholders 
 
Results obtained from the study will be disseminated through access to the published journal 
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This first section will explain theories of health inequalities that originated from the black 
report. The Black report proposed four theories — artefact, natural or social selection, 
cultural-behavioural and materialist/structural—to explain the root causes of health 
inequalities (Gray, 1982). Upon more research there are more theories that have been 
explained in the text.  
Immunisation is a key public health tool in averting child deaths from deadly diseases (Gram 
et al, 2014). Immunisation continues to be a serious topic globally and with the rollouts of the 
World Health Organisation’s (WHO)  Expanded Program on Immunisation (EPI) 
(Devasenapathy et al, 2016). In developing countries, disparities between the rich and the 
poor are large, limiting poorer group’s potential to contribute to economic growth (Lauridsen 
& Pradhan, 2011). Socioeconomic disparities in health are a major concern in developing 
countries because they make it difficult to attain the Sustainable Development Goals (SDGs) 
set by the United Nations (UN) (Lauridsen & Pradhan, 2011). 
Health inequalities have persisted through time and can be mostly found in low- and middle-
income countries (de Graaf et al, 2013). Following the WHO EPI schedule, 85% of children 
who die under the age of 5 are found in developing countries (Gram et al, 2014).  
 
Theories of inequalities in health 
It is important to understand what causes health inequalities to identify solutions to reduce 
them (McCartney et al, 2013). The Black Report published in 1980 identified four theory 
categories: artefact, health selection, behaviours (including culture) and structural/ 
materialistic factors as the root cause of inequality in health (Alonge & Peters, 2015). Over 
the years, there are more theories introduced, such as the intelligence and meritocracy 
theories that fall under the selection category (Etana & Deressa, 2012). Psychosocial and life 
perspective are also new theories discussed in this section  
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Health inequities are avoidable and unjust differences that are spread across a population and 
occur between specific population groups (Arcaya et al, 2015). According to the WHO, 
health inequalities are differences in health status or the distribution of health determinants 
between different population groups (Beenackers, 2018). A distinction between health 
inequality and equity is important. Equality means everyone has the equal opportunity to 
attain their full health potential while equity is making sure that equal opportunities are 
created according to need, and making sure that everyone receives services according to their 
need (Chang, 2002).  
Artefacts theory: It suggests that socioeconomic inequalities do not exist but are a result of 
methods of measurement and data (Bambra, 2011). Differences in health by socioeconomic 
status are explained by the differences in measurement, noting that the size of the inequalities 
identified is because of differences in data measurement tools (Bambra, 2011). 
Artefacts theory is more relevant to the measurement of social class. It urges us to look 
critically at how health and social class are measured and suggests that the apparent 
relationship between the two variables may be inherent in the measures themselves (Blane, 
1985). The health of a population can variously be measured by the rates of morbidity 
(condition of being unhealthy or ill) and mortality (death). The Black report was unable to 
explain this theory but showed an important point about the importance of taking note of how 
social classes impact, to a greater extent, the level and distribution of health (Smith et al, 
1990).  
 
Health selection: Selection theory sees an individual's health as having an important 
influence on their chances of social mobility and not vice versa (Blane, 1985). Individuals 
who are ‘fitter’ are more likely to be upwardly-mobile, and those in worse health are 
downwardly mobile and concentrated within the lower socioeconomic classes (Bambra, 
2011). This explanation, therefore, accepts a causal connection between health and social 
class and sees social class as the dependent variable (Blane, 1985). It suggests reverse 
causation: that poor health causes a social selection (a social slide) leading to the observed 




Intelligence: Health selection was rejected as a major health inequality explanation, but 
recently, there has been an attempt to reinvigorate the theory by a proposal of the role of 
intelligence (McCartney et al, 2013). Intelligence is a mental capability involved in the ability 
to reason, solve problems, among other things, and it reflects a broader and deeper capability 
for comprehending surroundings and making sense of things (Gottfredson, 2004). 
  
Health and intelligence are closely associated due to intelligence being a genetic endowment 
and because they are both caused by confounders such as socioeconomic status or early life 
experiences (Gottfredson, 2004).  
Meritocracy: The theory originated in Scandinavian countries which are considered more 
democratic and meritocratic than other countries (Warikoo, 2018). The more able individuals 
that are born into lower socioeconomic groups (those with higher intelligence) can rise to 
higher socioeconomic groups when they are adults. Vice versa, “less able” people born into 
higher socioeconomic groups can experience a socioeconomic-slide (Manor et al, 2003).  
 
Behavioural/ cultural: The link between behaviour and culture  is a result of the differences 
between socioeconomic class in terms of their health-related behaviours (Bambra, 2011). 
Certain behaviours like smoking, dietary intake, alcohol consumption, health service usage 
and physical activity that are different between groups contribute to health inequalities 
(McCartney et al, 2013). 
 
It is not accurate to say certain behaviours are linked to poorer people only because rich 
people can also eat the ‘wrong’ foods and may smoke and smoke as much as poor people. 
(McCartney et al, 2013).  
 
Structural/materialistic: Highlights levels of wealth and income. The materialistic theory is 
the most favoured explanation and notes that social class differences in health may be seen as 
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an inevitable consequence of the competitive accumulation of capital (Smith et al, 1990). At 
the intermediate level, health may be linked to factors such as income, poverty and access to 
education etc. Some studies have found that a wide range of diseases are associated with 
manual workers that are exposed to dust and chemicals and noise, and these are usually 
people of lower socioeconomic standing (Blane, 1985; Clougherty et al, 2010; Johansson et 
al, 2019). 
 
Life-course perspective: It combines aspects of other theories, allowing different causal 
mechanisms and processes to explain the social gradient in different diseases (Bambra, 2011). 
Health at adult ages is partly determined by experiences in early life: social, psychological 
and biological advantages and disadvantages over time (Mackenbach, 2012). There are 
critical development periods that affect health and may not be reversed. An example is poor 
nutrition in adolescence (a critical period for bone development) which can put an individual 
at risk for bone fracture when older (Arcaya et al, 2015). 
 
Psychosocial: Focuses on how social inequality makes people feel and how this affects their 
health and biological makeup (Bambra, 2011). Social inequality can have long term effects 
on people, making them feel inferior which can stimulate chronic stress with profound 
consequences for mental and physical health (Mackenbach, 2012). The socioeconomic class 
gradient is, therefore explained by the unequal social and economic distribution of 
psychosocial risk factors (Bambra, 2011). Psychological stress can lead directly to ill health 
by triggering a specific chain of events that can lead to specific diseases, or indirectly through 
its effect on behaviour and lifestyle that are damaging to heath (Alonge & Peters, 2015).  
 
METHODOLOGICAL REVIEW  
This section will give an overview of the methods used to measure socioeconomic 
inequalities in health.    
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A relative inequality index has a value that remains constant for any proportional change of 
the variable of interest (health and health care). An absolute inequality index is a character 
translation-invariant: adding the same amount of health services to everyone changes the 
inequality index. (Erreygers & Van Ourti, 2011).  
 
Overview of common measures of health inequalities  
Methods to measure inequality  
Wagstaff et al (1991b) outline six measures of inequality that have been used to date in the 
literature on inequalities in health.  These measures include the Gini coefficient (and the 
associated Lorenz curve), a pseudo-Gini coefficient (and an associated pseudo-Lorenz curve), 
the index of dissimilarity, the slope index of inequality (and the associated relative index of 
inequality) and the concentration index (and the associated concentration curve). The range is 
another measure that has been added with time that has become very popular in the literature 
(Alonge & Peters, 2015). 
 
Gini index/ Lorenz curve  
The Gini index is derived from the Lorenz curve, where the x-axis is the cumulative 
proportion of individuals by the level of health, ranked in ascending order, from the sickest 
persons ending with those that are healthy (Regidor, 2004a). The Gini index is derived from 
the Lorenz curve as two times the area between the Lorenz curve and the line of equality. The 
y-axis represents the cumulative health of these people. The Lorenz curve is diagonal when 
health is equally distributed among individuals; otherwise, it lies underneath the line 
(Wagstaff et al, 1991b). The more it deviates from the diagonal the greater the health 
inequality. The magnitude of the index ranges from 0- where curve coincides with the 
diagonal line to 1- when all the health of the population is concentrated in a single person 






Figure 1: Lorenz curve 
 
Source: (Regidor, 2004a) 
Advantages of the Lorenz curve includes how it represents the experiences of all persons and 
not just those in social classes, and it does not involve stratifying the population. By not 
stratifying the population by social class it allows one to side-step the issues associated with 
classifying people by social class (Dardanoni & Forcina, 1999). The disadvantage of the 
approach The Lorenz curve may understate the actual amount of inequality if the situation is 
that richer households are able to use income more wisely than lower income households 




Pseudo Lorenz curve 
Because the population is assigned to groups according to their social class rather than their 
health (though the classes are ordered according to health)  
 
The formula above is used to calculate the Gini index. Where pi and qi represent, 
respectively, the proportion of individuals by health level and the cumulative total proportion 
of health of these individuals (Alonge & Peters, 2015). The pseudo-Lorenz curve uses groups 
rather than individual data, unlike the Lorenz curve. Groups are occupational classes and not 
health classes which are ranked by mortality ranked from lowest mortality class to highest 
mortality (Wagstaff et al, 1991a). The pseudo-Lorenz curve, like the true Lorenz curve, fails 
to reflect the relationship between inequalities in health and SES (Sibanda & Doctor, 2013; 
Wagstaff et al, 1991a). 
 
Index of dissimilarity  
The index of dissimilarity represents the proportion of total health that would need to be 
transferred from the healthy to those whose health is below average to achieve a situation of 
total equity (Regidor, 2004a). It assumes that socioeconomic inequalities are derived from the 
inefficient distribution of resources (Sibanda & Doctor, 2013). The weakness of this method 
is that it is insensitive to socioeconomic dimension to inequalities in health, meaning it does 
not pay particular attention to where high morbidity or mortality are located in any 
socioeconomic group (Sibanda & Doctor, 2013).  
 
The slope index of inequality  
The slope index of inequality is a linear regression coefficient that shows the relationship 
between the level of health in each socioeconomic group and the ranking of each 
34 
 
socioeconomic category on the social scale (Regidor, 2004b). It is sensitive to local 
population characteristics (e.g. location of care homes, accuracy of local population data for 
small areas).  In some cases, this can lead to inconclusive results.  
 
The range  
Typically involves comparing the experiences of the top and bottom socioeconomic groups 
(Munoz-Arroyo, 2007). Comparison is presented as absolute range but more often as the ratio 
of one extreme value to the other (relative range) (Munoz-Arroyo, 2007). 
An advantage of the relative range concept is that inequality can be compared for rates of the 
outcome on different scales (Alonge & Peters, 2015). A disadvantage of this approach is that 
it overlooks what is happening in the intermediate groups. It does not consider the sizes of the 
groups being compared and this can distort results when making comparisons over a long 






Source: (Phiri & Ataguba, 2014a) 
The concentration index is based on the concentration curve. Here, the x-axis represents the 
cumulative proportion of individuals by socioeconomic category ranking them from those with 
the lowest level up to those with the highest socioeconomic level while the y-axis represents 
the cumulative proportion of health in these individuals (Regidor, 2004b). The concentration 
index ranges from -1 to +1 and is calculated as twice the area between the concentration curve 
and the line of equity (O’Donnell et al, 2008). Like the Lorenz curve, if the concentration curve 
coincides with the diagonal (i.e. the line of equality), all individuals have the same health 
(Erreygers, 2009). When the curve lies above the line of equality, health is concentrated more 
towards the poor, and when it is underneath the line of equity health is concentrated more on 
the rich (O'Donnell et al, 2016). It includes all individuals in a population and is sensitive to 
changes in the distribution of the population across different socioeconomic categories 




Standardisation of the concentration index 
The concentration index is standardised by sex and age as a way to reduce confounding effects 
of demographics on a health variable (Ataguba et al, 2011). Widely denoted as the age-sex 
standardised distribution because these confounding variables are correlated with measures of 
socioeconomic status and affect health (Kakwani et al, 1997). It is, therefore, an alteration 
procedure that is utilised to: 
 
i reflect differences in the population demographic structure  
ii establish a refined and validated description of the association between health and 
socioeconomic status  
iii compare estimates over time and across populations or sub-populations (O'Donnell et 
al, 2016) 
There are two methods used to standardise: direct and indirect method (Kakwani et al, 1997; 
Nicholl et al, 2013). Direct standardisation determines the distribution of health or ill-health 
across income or SES groups that would be observed if all groups were identical age/sex 
structure but group-specific intercepts and age effects. The method makes use of grouped 
data, requiring individuals to be divided into random groups of living standards (Kakwani et 
al, 1997). Some scientists have criticised the method on the basis that created groups alter the 
numerical values of inequality measure, claiming that the method exhibits a greater reliance 
on the number of selected SES groups (Ataguba et al, 2011; Kakwani et al, 1997). 
 
The indirect method uses individual-level data and attempts to correct the actual age/sex 
distribution by comparing to the distribution that would be experienced is individuals had their 
own age but the same mean age/sex effects as the entire population (O'Donnell, 2008). The 
method involves substituting an individual degree of illness with a degree of illness suffered 
on average by a person of the same age and sex (Gravelle, 2003). The indirect method is the 
more favoured approach because it has greater accuracy when dealing with individual-level 




Correction of the concentration index 
The concentration index has been widely used and has shown desirable requirements of 
health inequality indices, though it needs to applied with caution as it is reliant upon the 
nature of the dependent variable (Van Doorslaer et al, 1997) In theory, CI requires 
unbounded or continuous variables measured on a ratio scale. In practice, however, many 
measures of health outcomes tend to be bounded (0, 1) or binary and measured on an ordinal 
or cardinal scale, such as self-assessed health (Erreygers, 2009). When the health variable is 
binary, scientists have highlighted the following shortcomings of the CI:  
i The bounds of the standard CI depend upon the mean of the health (ill-health) 
indicator and hence a comparison across populations with different mean levels is 
not suitable. In large samples, the lower and upper bounds of the computed CI are 
not necessarily –1 and +1, respectively, but rather between μ −1 𝑎𝑎𝑎𝑎𝑎𝑎 1−μ 
(O'Donnell, 2008). 
ii  “Different rankings are obtained when one compares ‘inequalities in health with 
inequalities in poor health33. This is also referred to as “a mirror problem (Clarke et 
al, 2003). 
iii  The value of the index becomes “arbitrary” if health variables are qualitative in 
nature (Clarke et al, 2003). 
Both Wagstaff (2005) and Erreygers (2009) propose different normalisation and correction 
techniques of these shortcomings. Wagstaff (2005) suggests a normalisation process that 
involves dividing the concentration index by (1−𝜇𝜇). Both Wagstaff’s normalised index (W) 
and Erreygers’ corrected index (E) belong to the same “family of rank-dependent measures of 
socioeconomic inequality” and satisfy the mirror condition as well as the scale-invariant for 
cardinal outcomes (Erreygers, 2009; Wagstaff, 2005). Erreygers declares that his index (E) is 
superior and more appropriate than the traditional CI and W. This is partly because the E 




In his criticism of the Wagstaff’s normalisation of CI index Erreygers (2009 p. 523) points 
out:  
i  “Wagastaff’s index(W) does not possess the mirror property”;  
ii W “blow(s) up the levels of measured inequality for the distributions with either 
high or low means” whereas Erreygers (2009) proposes an index that avoids this 
situation.  
Wagstaff (2009) argues in return that Erreygers’s corrected CI is an index of absolute 
inequality and that Wagstaff’ s index was never intentionally created to measure absolute 
inequality. The magnitude of measured inequality may change, there is little variation 
between the normalised index, as suggested by Wagstaff, and the standard CI. The ordering 
of inequality remains the same for both correcting measures, and produce identical results. 
Erreygers’ index could be derived by scaling Wagstaff’s normalised index if a binary health 
variable is used (Ataguba et al., 2011).  
 
EMPIRICAL REVIEW  
Search strategy  
Literature was sourced from Google scholar, EBSCOHost, PubMed, Medline and Cochrane. 
Further, the search was manually done from cited literature in other articles. Key search terms 
used included immunisation/ vaccinations, socioeconomic, inequality in health, disparities in 
health, assessing/explaining. Boolean operators (AND and OR) were used to combine 
searches.  
Inclusion and exclusion criteria: Excluded papers that had children who were below 12 
months of age because full immunisation is achieved at 12 months. Included papers that 
explained or identified socioeconomic inequalities and were able to identify inequalities 
found among the 12-59 months age group when it came to immunisation coverage.  
Main inclusion criteria were studies that sought to explain socioeconomic inequality in 
immunisation coverage, and written in English. 
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Objective: The objective of the empirical review is to analyse literature to understand more 
of socioeconomic inequalities associated with children being immunised all around the world. 
Sub-Saharan African has significant inequalities but there is a dearth of research to explain 
why these disparities persist. The purpose of the review is to identify gaps in the literature 
that can situate this study.  
The empirical section aims to compare literature among different countries to see if there is a 
common use of certain methods of measuring socioeconomic inequality in child 
immunisation coverage. Comparison of the results would shed light on the things that are 








Table 1   Summary of empirical studies of socioeconomic inequalities in developing and developed countries  




and year of 
analysis  
Objectives of 





























































played a crucial role in 
immunisation. It was 
generally just important 
to educate mothers on 
the importance of 
getting their children 
vaccinated  
 
Disparities exist in 
immunisation coverage 
to the advantage of the 
rich 
 
Inequality in partial and 
no immunisation is 
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more towards poor 
children  
 
People who resided in rural 
areas had lower 
immunisation coverage as 
well as those situated in 
certain geopolitical regions  
 
Yu Hu, 
Ying Wang,  





































children from higher 
SES 
 
Mothers education is 
the biggest contributor 
to low immunisation 
coverage  
 
Children in rural areas were 
more advantaged to receive 
full immunisation due to a 
rise in urbanisation that 
created a weak connection 
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between patients and clinic 
staff and the difference in 
public health delivery in the 








































status, education and 
work status contributed 
to low self-rated health  
 
Residence in rural 
(Northeast) resulted in 
low immunisation due 
to barriers though  
Thailand has achieved 







6th wave of 
DHS 
conducted in 
2008 & 2014 






























































Children in rural areas 
are more likely to be 
fully immunised  
 
Due to high 
urbanisation, there 
should be a policy that 
looks at the vulnerable 
children that live in 
slums  
 
Mothers with health 
insurance were at a better 
advantage to get children 
immunisation because they 
were able to visit the health 
facilities more often even 
for their health, which could 
allow nurses to check on 
their children  
 
Younger mothers were 
believed to have lower rates 
of getting children 
immunised because they 
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would need to seek 
permission from someone 
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Children with mothers 
with secondary 
educated were more 
likely to be vaccinated. 
 
Firstborn children more 
likely to be fully 
vaccinated than, say, 
the sixth child  
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are more likely to die in 
their first year. 
 
Infant mortality is 
greater among the poor 
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the size of the family  
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Most deprived groups 
were more likely to 
delay in getting their 
children vaccinated 




Findings of the review  
Literature search results have mainly presented papers from developing countries, possibly 
because they usually have intervention related papers. A total of fourteen papers were 
reviewed in this paper; four papers from developed countries and ten from developing 
countries under the United Nations categorisation. Five studies were from sub-Saharan Africa 
(Kenya, Ghana, Zimbabwe, including Togo and Gambia that were part of a multi-country 
analysis paper). Four studies from Asia (China, Thailand, Bangladesh and India). One study 
was from South America (Brazil) and three from Europe (Ireland, Belgium & Scotland). A 
multi-country study was also included.  
The use of the concentration index and decomposition analysis was observed in seven of the 
papers. The logit regression was used in two papers, one paper used the bivariate and 
multiple regression model. One paper used the cox regression analysis and chi-squared 
analysis. The last method that was used was the multivariate binary regression analysis that 
was used in two studies. The main health outcome that was observed in the papers was to 
improve immunisation coverage 
Studies have shown that in low- and middle-income countries, health outcomes and access to 
keys services are unevenly distributed across different subgroups in a population and across 
countries (Skaftun et al, 2014). There is a trend of a social gradient in the majority of the 
papers that have been reviewed under the notion that health outcomes improve the higher the 
socioeconomic status a person (Hämmig & Bauer, 2013). Socioeconomic status was a key 
element in all 11 papers reviewed and there has been a consensus in the findings that 
immunisation coverage is higher among higher socioeconomic groups. In the Gambia, 
Namibia and the Kyrgyz Republic (Hajizedah et al, 2018), children who belonged to higher 
socioeconomic groups received fewer immunisation. 
Maternal effects on child immunisation coverage are an important aspect (Mohamud et al, 
2014; Vasudevan et al, 2014). Having identified this, it is important to realise that many 
policies would be tailored to help women become independent and able to provide for their 
children. Mother’s education was the highest-ranked variable in the majority of the papers 
(Ataguba et al, 2016; Egondi et al, 2015; Hu et al, 2017; Lauridsen & Pradhan, 2011; 
Mukungwa, 2015). The only study where the education of the mother was not equally as 
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important was Ireland, where income and household structure were very important (Doherty 
et al, 2014). Negative experiences in health facilities also played a major role in determining 
vaccination delays in Scotland (Haider et al, 2019). Delays in children being vaccinated 
contributes to outbreaks that are still observed (Tiley et al, 2018) 
Most immunisation interventions are pro-rich meaning they are in favour of the rich. Urban 
areas usually present with higher coverages but in this review, there were two studies where 
rural areas had higher coverage—in China and Ghana (Asuman et al, 2018; Hu et al, 2017). 
These countries have governments that came up with many health interventions that included 
increasing health facilities and increasing interventions such as nurses visiting homes and 
carrying out vaccinations within communities (Saeterdal et al, 2014). These studies also 
managed to have high coverage in rural areas because of the engagement between health 
workers and mothers and they were able to educate them more on the importance of 
vaccinating their children, which was not the case in urban areas where there is high 
urbanisation which increases demand for health workers there limiting tome they have per 
patient (Hu et al, 2017). Zimbabwe on the other had no difference between the rural and 
urban areas (Mukungwa, 2015) 
Thailand is the only Asian country in the reviewed papers that has attained universal health 
coverage though people residing in rural areas have low immunisation coverage 
(Yiengprugsawan et al, 2010). There are barriers that people in rural areas usually face which 
are acceptability, affordability and availability (Nabyonga-Orem et al, 2014). Health 
insurance may be a barrier for women who do not have it because they are afraid they will be 
made to pay even though services are free but lack of knowledge affects coverage of 
immunisation (Asuman et al, 2018). 
In all the reviewed papers, immunisations are free in the public sector , which should 
automatically narrow SES inequalities but there are indirect costs that can be a barrier such a 
transport cost for patients who live far from health facilities (Tajima-Pozo et al, 2015). The 
opportunity cost for poor mothers makes them rather work than spend the whole day at the 
clinic and forego some income which was shown in the results of most of the studies (Phiri & 
Ataguba, 2014b). Mothers who are employed could sometimes negate taking their children to 
the clinic though they are at a better position than those who are not employed or are self-
employed (Hu et al, 2017) 
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There may not have been many developed country studies on this topic because most of them 
have achieved universal immunisation coverage according to UN statistics and they are trying 
to eliminate diseases as opposed to most developing countries that are trying to increases 
coverage (Wiysonge et al, 2012). Most developed countries have passed the 90% 
immunisation coverage mark such as Ireland at 95%, Canada at 91%, Italy at 94%, France at 
96% and Switzerland at 97% coverage (UNICEF, 2018). Minorities in developed countries 
are the ones usually affected, who in most cases are usually migrants and people of 
marginalised ethnic groups (Joseph & Marrow, 2017; Tiley et al, 2018). The household 
structure, income and SES and health behaviours such as smoking were the main contributors 
to disparities in immunisation coverage with little effect on the age, literacy, birth order 
(Doherty et al, 2014) 
Andrew Wakefield, a British doctor, published an article in 1998 that concluded that 
immunisations cause autism among children (Rao & Andrade, 2011). Although this article 
was revoked after many studies revealed that the conclusions were false, there had been 
ripple effects among parents being hesitant to get their children immunised (Rao & Andrade, 
2011). Social attitudes and perceptions contribute to barriers against some of the 
immunisation coverage that has been observed in countries such as the United States of 
America and Scotland (Arede et al, 2019; Haider et al, 2019). Religion is another social 
variable that was tested in Ghana and results showed that Christians and Muslims were more 
likely to get their children fully immunised compared to Buddhists (Asuman et al, 2018). 
Access to Television and radio was considered an important factor that allowed mothers 
access to better information regarding immunisation schedules (Handy et al, 2017).  
Region of residence usually plays a role because in countries such as Zimbabwe there are 
regions such as Bulawayo that have better development than Mashonaland which has a lot of 
rural areas and coverage is different between the two regions (Mukungwa, 2015). Kenya, 
Ghana and India have low immunisation coverage in the slums that are found in the urban 
areas which are also a comparison within the same region but urbanisation has forced the 
slums to grow bigger and generally, there are bad sewage systems, unsafe water and 
unhealthy living conditions which make people prone to sickness and outbreaks are easily 




Antenatal care (ANC) visits for pregnant mothers improved their access to nurses which 
improved their chances to get information on immunisation dates (Asuman et al, 2018; Dixit 
et al, 2013). ANC visits were linked to the place of delivery which was important because a 
child born at home would not immediately get the BCG vaccine that they are supposed to 
receive and depending on the knowledge of the mother, they may automatically fall back on 
the number of vaccines their child needs (Gupta et al, 2016; Meleko et al, 2017).  
Birth order was revealed to affect immunisation coverage in all the reviewed papers except in 
Nigeria, Kenya, Ireland and the multi-country analysis (Doherty et al, 2014; Egondi et al, 
2015; Hajizadeh, 2018). Children of higher birth order were less likely to be fully immunised, 
due to reasons such as ‘parents vaccine fatigue’ which means parents get tired of the same 
cycle of going with their children for vaccines but there are other explanations such as the 
fact that there will be sibling competition to get the parents attention (Hu et al, 2017).  
Studies in Kenya and Belgium highlighted that the age of the mother played a crucial role 
which was supported by a Zimbabwe study. The older the mother, the more likely the child 
was to be immunised (Egondi et al, 2015; Lernout et al, 2014). The Ghanaian study by 
Asuman (2018) also supported the idea that younger mothers may not have as much 
bargaining power as they may have to seek permission from someone else in the household 
which will likely affect the timing of vaccines or even missing some of the dates. China, on 
the other hand, disagreed with this theory and believed that younger mothers would have 
better utilisation of health services allowing them to have a higher immunisation coverage 
(Hu et al, 2017). Maternal age had no significance in Brazil and England (Branco et al, 2014; 
Tiley et al, 2018). 
The fact that sub-Saharan has the highest rates of child mortality in the world is important 
that more countries in this region seek to explain factors that hinder immunisation coverage 
being achieved. Zimbabwe does not have a study of this nature that seeks to explain 
socioeconomic inequalities in immunisation coverage which makes this study important. 
Variables that were used in other studies shall be tested to see if they fit in the Zimbabwean 
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Background: Socioeconomic inequalities in health have received significant attention globally 
because of the well-known association between wealth and health. A lot of studies show that 
poor people are more prone to sickness than their counterparts. Immunisation has been a key 
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antidote to avert deaths for children under the age of 5. This study represents an initial attempt 
to assess specific variables that contribute to socioeconomic inequalities in immunisation 
coverage in Zimbabwe. 
Methods: Data were obtained from the 2015 Zimbabwe Demographic Health Survey, a 
nationally representative survey. Immunisation coverage was measured using four categories: 
full immunisation (a child who will have received 10 doses of vaccines), partial immunisation 
(a child who will have received at least one but not all vaccines), no immunisation (a child who 
will not have received any immunisation dose from birth) and immunisation intensity (a 
proportion of doses received to total doses that they should have received). Inequalities in 
immunisation coverage in Zimbabwe were assessed using concentration curves and indices. A 
positive (negative) concentration index indicates immunisation coverage concentrated among 
the rich (poor). The concentration index was decomposed to identify how different variables 
contribute to the socioeconomic inequality in immunisation coverage in Zimbabwe. 
Results: The immunisation intensity and full immunisation concentration indices were 
(0.0154) and (0.0250) respectively, indicating that children from lower socio-economic status 
are less likely to receive all doses of vaccines. No immunisation and partial immunisation 
concentration indices were (-0.0778)  and (-0.0878) indicating that children from higher socio-
economic status  are more likely to have their children immunised opposed to their poor 
counterparts. The main contributors to socioeconomic inequality in immunisation coverage are 
the mother’s education, socioeconomic status and place of residence (rural/urban and 
province). 
Conclusion: While immunisation services are free of charge in the public health sector in 
Zimbabwe, coverage rates are higher among the wealthy, which shows that there may be 
barriers to utilising these services that may not be the direct cost of vaccination. There have to 
be measures by the government to reach people in areas that are not easily accessible. Also, 
more needs to be done to reduce socioeconomic inequalities in Zimbabwe.  
Keywords: Immunisation, socioeconomic, inequality, decomposition, Zimbabwe, 





Child mortality is a key health topic of concern globally, falling under the third goal of the 
seventeen Sustainable Development Goals (SDGs) (Lauridsen & Pradhan, 2011). Under 5 (U5) 
mortality rate has decreased by 58% globally. In 2018, one in 26 children died before they 
reach the age of 5 compared to one in 11 children in 1990 (UNICEF, 2018). The World Health 
Organization (WHO) introduced the Expanded Program on Immunisation (EPI) in 1974 to 
avert childhood immunisation-related deaths.  The EPI has proven to be a cost-effective 
solution used to reduce child deaths from preventable diseases especially in developing 
countries (Keja et al, 1988). 
In 2017, an estimated 6.3 million children under the age of 15 died; about 5.4 million of these 
deaths were children under the age of 5. Even though immunisation has improved, reducing 
the number of U5 deaths from 12.6 million to 5.4 million between 1990 and 2017, an estimated 
19.9 million children did not receive the 3 doses of DPT (diphtheria, pertussis, and tetanus) 
(WHO, 2017).  
Under 5 deaths are mainly caused by pneumonia, diarrhoea, malnutrition, and malaria (WHO, 
2017). Despite the decrease in mortality rates, there are still disparities between countries and 
regions (Raza et al, 2018). Sub-Saharan Africa is the region with the highest proportion of child 
deaths as children are 15 times more likely to die in the region compared to other regions. In 
2018 the mortality rate in sub-Saharan Africa was 78 deaths per 1000 live births (UNICEF, 
2019). The major reason for the disparities between regions is incomplete or no vaccinations 
(Donfouet et al, 2019; Mackenbach et al, 2003). As the world progresses and nations become 
richer, gaps in socioeconomic inequalities in health in some countries have also widened 
(Mackenbach et al, 2003). This phenomenon goes against the 1978 Alma Ata declaration that 
advocated the need to bridge the gap between the rich and the poor in accessing health services 
(Gillam, 2008). These gaps limit poor people’s full capacity to function and contribute fully to 
the economy due to poor health (Bloom et al, 2004). A vibrant economy needs to ensure that 
people are healthy so that they can contribute to economic growth (Adams, 2009). 
Perpetuating inequalities among different socioeconomic groups within society create a 
poverty trap for the poorest (Carter & Barrett, 2006). Many countries in sub-Saharan Africa 
face great inequalities due to unstable political and economic atmospheres and one of those 
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countries is Zimbabwe (Mbaku, 1988). The poverty rates in Zimbabwe have increased as the 
country’s economic growth has been declining (Stoeffler et al, 2016) 
Zimbabwe had an estimated population of 16.7 million people and an HDI of 0.535 in 2018 
which is very low (UNDP.). It introduced the EPI in 1981 to fight against 6 vaccine-preventable 
diseases: measles, tuberculosis, pertussis (whooping cough), diphtheria, tetanus and 
poliomyelitis (Mukungwa, 2015). In 1990, the country had attained universal child 
immunisation with a high reduction in mortality and morbidity. Poor economic performance 
has largely affected full immunisation coverage causing it to decline from 91% in 2016 to 89% 
in 2018 (Sibanda & Doctor, 2013). 
The infant mortality rate in the country in 2015 was estimated at 36 deaths per 1000 live births, 
and the under-5 mortality rate was 69 deaths per 1000 live births (UNICEF, 2018). HIV and 
AIDS had been a significant contributor to the high child mortality rates in the country, 
accounting for about 21% of child deaths (WHO, 2018). As a way to reduce the mortality rates, 
in 2017, the government of Zimbabwe removed user fees for the vulnerable population 
(children under the age of 5, pregnant mothers, and citizens over the age of 65 years) (Meessen 
et al, 2011). Removing user fees is a pro-poor policy in health aimed to increase the use of 
health services for those of lower social status in society with the intent to improve health 
outcomes and offer financial protection (James et al, 2006). 
Vaccine services are free of charge in the public sector, yet the poor still do not utilise these 
services as much as they should, which is reflected by lower immunisation coverage among 
the poor (Mukungwa, 2015). Access barriers can explain this inconsistency: Indirect costs 
(affordability) such as transport and food costs can play a role in them being unable to access 
health services (Goudge et al, 2009). There are other access barriers affecting immunisation 
services such as long walking distances to clinics especially in rural areas, poor service delivery 
brought by poor governance that enable problems like drug stock-outs and obsolete equipment 
(availability) (Gupta et al, 2016; LUCAS et al, 2009). Drug stock-outs can affect caregivers 
trust in travelling long distances and possibly not having their child (ren) vaccinated. Drug 
stock-outs have been a serious issue despite the high demand for drugs from patients, which 
can be frustrating for nurses because they are unable to do their job efficiently without patients 
feeling discontent (Gilson & McIntyre, 2005). Acceptability from expectations that patients 
have and the attitudes that health workers have also played a very crucial role, essentially if 
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caregivers are not treated fairly with health workers they can decide not to seek immunisation 
services (Goudge et al, 2009) 
Financial protection is essential for a pariah state like Zimbabwe with a high rate of 
unemployment (Rusvingo, 2014). Majority of people work in the informal sector and this has 
a ripple effect on most of the country’s sectors, especially the health sector. The government is 
unable to collect revenue from taxes that is sufficient to fund public programmes. Most funding 
of EPI comes from out of pocket payments and NGOs. UNICEF, WHO, GAVI and MCHIP 
are the main financers of supplies, medicines, equipment etc (Ministry of Health and Child 
Care, 2016). The government mainly only supports the program in terms of salaries and 
allowances for staff. Due to this, the government only allocated 7% of the national budget to 
the health sector in 2017, which is insufficient to pay salaries; hence, there is a serious staff 
shortage in the sector (Kidia, 2018). The shortage of staff is met with an increase in health 
services utilisation associated with the removal of user fees (Meessen et al, 2011). This free 
user policy has put a strain on the short-staffed workforce with a doctor-patient ratio of 
1:250,000 (Kidia, 2018), compared to the World Health Organization recommended doctor-
patient of 1:1000 (WHO, 2019).  
Like many developing countries, Zimbabwe is heavily reliant on donor funding, but donors 
usually come with their agendas and the government is unable to divert funds to issues that 
may deem more necessary than others (Salama et al, 2014). There is need for the government 
to be able to come up with ways to increase its internal financing so that it is able to allocate 
resources to pressing issues such as increasing immunisation coverage across all SES groups. 
There is consistent evidence globally and in Zimbabwe on the social gradient, where people of 
lower socioeconomic status suffer a greater burden of illness, having higher mortality rates 
compared to their better-off counterparts (Gwatkin, 2000b). This inverse care relationship 
explains that people who need health services (usually the poor) do not use them and vice versa 
(Warren, 2009).  
Knowing the social gradient, the specific factors that contribute to socioeconomic inequalities 
must be identified so that governments are able to tackle each factor individually. This study 
is the first to decompose health inequalities in Zimbabwe and seeks to make policymakers 
aware of disparities that are observed between different SES groups in the country so that they 
can address issues to allow equal opportunity for all to access good health. Better governance 
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would allow for better allocation of resources, but the ultimate goal is for immunisation 




This study uses data from the sixth wave of the Demographic Health Survey (DHS), conducted 
in 2015.  This is the most recent DHS conducted in conjunction with the government of 
Zimbabwe. The primary objective of the survey is to provide demographic and health 
information(ZIMSTAT & ICF International, 2016). The DHS uses a two-stage sampling 
method, involving a selection of 400 enumeration areas (EAs), 166 in urban areas and 234 in 
rural areas, in the first stage. A total of 11,196 households were sampled in the second stage, 
using a stratified method. The main advantage of the DHS dataset is that it has a high response 
rate of 99%  
Box 1: Zimbabwe immunisation schedule for children under 12 months 
Source: Ministry of Health and Child Care (2017) 
 
 
First contact at birth – BCG 
Second contact at 6 weeks – OPV 1, DTP-HepB-Hib1 (Pentavalent), PCV 1, Rotavirus 1 
Third contact at 10 weeks – OPV 2, DTP-Hep B-Hib 2 (Pentavalent), PCV 2, Rotavirus 2 
Fourth contact e at 14 weeks – OPV 3, DTP-Hep B-Hib 3 (Pentavalent), PCV 3, IPV 
Fifth contact at 9 months – Measles and Rubella vaccine 
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The data set had information on 6132 children. About 81% (4904) of the children are aged 
between 12 to 59 months, are then used to create a sub-sample used for the study analysis. 
Children aged 12 months were the cut off age because that is the age at which full immunisation 
can be observed (i.e. where a child has received all 10 doses required). It is important to note 
that this paper uses 10 vaccines in the analysis as opposed to the 14 shown in Box 1 above. 10 
vaccines are used because the rotavirus was introduced in 2014, a year before the survey, which 
would not have given a good reflection of the number of children who received the dose. 
Specifically, rotavirus 1 and 2 were dropped. The Inactivated Polio Vaccine (IPV) was also 
introduced in 2019 which is an obvious exclusion. Measles and Rubella was a supplementary 
dose introduced in Zimbabwe in 2015 and may not be included in the mainstream vaccine doses 
or collected in the 2015 DHS data. After removing these 4 doses due to the reasons mentioned 
above, the remaining 10 doses were used to categorise children into different immunisation 
coverage indicators.  
 
In a majority of DHS surveys, people eligible for individual interviews include women of 
reproductive age (15-49 years) and men (15-59 years). Individual questionnaires include 
information on fertility, mortality, family planning, marriage, reproductive health, child health, 
nutrition, and HIV/AIDS (ZIMSTAT & ICF International, 2016). 
In the analysis, four indicators of immunisation coverage are created, namely: fully immunised 
(children from the age of 12 months that received all 10 doses of vaccines), partially immunised 
(children who received between 1 and 9 doses of vaccines) and not immunised (children who 
never received a dose of vaccine from birth). The partially immunised group made way for a 
fourth group that measures immunisation intensity (the proportion of the 10 doses of vaccines 
received at 12 months).  
Wealth Index 
The wealth index used as the SES measure was constructed within the DHS dataset using a 
method developed by Rustein and Johnson  (Rustein, 2004). The index uses several household 
assets, including the source of drinking water, type of flooring and ceiling in the house and 
sanitation facilities. This is done in 3 steps: (1) a subset of indicators that are common to rural 
and urban is used to create wealth scores for each household in both areas and transformed into 
76 
 
binary indicators. A principal components analysis method is then used to create wealth scores 
for every household. (2) Households in rural and urban areas have separate factor scores using 
area-specific indicators, and (3) the last step combines the specific area indicators to produce a 
national wealth index. The wealth index is essential for plotting the concentration curves and 
computing the concentration index (Rustein, 2004). 
 
Analytical methods  
This study used the concentration curves and concentration indices (CI) over other measures 
such as the slope index of inequality, index of dissimilarity and pseudo-Lorenz curve, to assess 
health inequalities in immunisation coverage (Regidor, 2004a). The concentration index fulfils 
certain properties: it is widely used because it consistently reflects the socioeconomic 
dimension of health, it is sensitive to changes in the distribution of the population across 
different socioeconomic categories and reflects the experiences of all people rather than just 
the top and bottom SES groups (Regidor, 2004a; Zhang & Wang, 2007). It can assess relative 
rather than absolute inequality (Asada, 2010; Ataguba et al, 2016). Relative inequality refers 
to the idea that measurement of inequality should not depend on the mean health/ill-health such 
that if everyone’s health doubled, inequality measures would not change (Asada, 2010; 
Wagstaff, 2009). 
As a way to reduce any confounding effects of some variables correlated with SES and 
immunisation coverage, the health variables are indirectly standardised by age and sex (Naing, 
2000). Standardising attempts to correct the distribution of immunisation coverage by 
comparing it with that expected of actual age/sex distribution of children. It, therefore, 
produces the distribution of immunisation coverage by SES conditional on the confounding 
variables (age and sex) (Ataguba et al, 2016). The indirect method was used in this study 
because it has greater accuracy when dealing with individual-level data unlike the direct 
method which could alter the standardised concentration index according to the number of 
age/sex groups formed (Ataguba et al, 2016; O'Donnell, 2008). O’Donnell (O'Donnell, 2008) 
estimate a health regression as:  
𝑦𝑦𝑖𝑖 = 𝛼𝛼 + ∑ 𝛽𝛽𝑗𝑗𝑥𝑥𝑗𝑗𝑖𝑖 + ∑ 𝛾𝛾𝑘𝑘𝑧𝑧𝑘𝑘𝑖𝑖 + 𝜀𝜀𝑖𝑖𝑘𝑘𝑗𝑗                                                         (1) 
77 
 
where yi is the immunisation coverage indicator (e.g. full immunisation); i denotes the case 
1individual; and α, β, and γ are parameter vectors. The xj are confounding variables for which 
we want to standardise (e.g., age and sex), and the zk are non-confounding variables for which 
we do not want to standardise but to control for to estimate partial correlations with the 
confounding variables (O'Donnell, 2008). 
 
Estimates of indirectly standardised health 𝑦𝑦�𝑖𝑖𝐼𝐼𝐼𝐼 are given by the differences between actual 
and x-expected health (using equation 1) plus the overall sample mean. 
𝑦𝑦�𝑖𝑖𝐼𝐼𝐼𝐼 = 𝑦𝑦𝑖𝑖 − 𝑦𝑦�𝑖𝑖𝑋𝑋 + 𝑦𝑦�                                                  (2) 
The concentration index is derived from the concentration curve. The x-axis ranks individuals 
in ascending order of their socioeconomic status, starting with those with the lowest 
socioeconomic status. The y-axis plots the cumulative share of a health variable (i.e. 
vaccination coverage) (Phiri & Ataguba, 2014b). The concentration index is twice the area 
between the 45-degree (line of perfect equality) and the concentration curve. The concentration 
index ranges from -1 to +1 (Jann, 2016). A key characteristic feature of the concentration index 
is that it takes account of every individual’s level of health and rank when measuring 
socioeconomic inequality (Erreygers & Van Ourti, 2011). 
 
A negative concentration index means that the immunisation coverage variable is mainly 
concentrated among the disadvantaged SES group and a positive concentration index means 
the opposite. A value of zero means there is an equal distribution between the rich and the poor. 
The larger the value of the CI, the wider the inequalities in the coverage of immunisation.  
Wagstaff takes note that the concentration index of a binary variable (such as immunisation 
coverage) does not have the usual bounds. It lies between (μH – 1) and (1 – μH) requiring 
normalisation by dividing by (1 – μH) (Wagstaff, 2005), where μH is the mean of the 
immunisation coverage variable. On the other hand, Erreygers views this normalisation as ad-
hoc and proposes another way of normalising the concentration index for an ordinal variable 
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as well as a dichotomous variable (Erreygers, 2009). Wagstaff has shown that Erreygers’ 
(Erreygers, 2009) adjusted concentration index, Ec, can be written as: 
𝐸𝐸𝐸𝐸 = 4 � 𝜇𝜇𝐻𝐻
𝑏𝑏−𝑎𝑎
� ⋅ 𝐶𝐶𝐶𝐶                                                                           (3) 
where a and b are the lower and upper bounds of the variable of interest, respectively and 𝐶𝐶𝐶𝐶 is 
the concentration index. 
Decomposing the concentration index  
Decomposing the concentration index allows for an explanation of the factors that contribute 
to socioeconomic inequalities (Hosseinpoor et al, 2006).  
Let the relationship between each immunisation coverage variable and the relevant determinant 
factors be given as: 
𝑦𝑦𝑖𝑖 = 𝛼𝛼 + ∑ 𝛽𝛽𝑘𝑘𝑥𝑥𝑘𝑘𝑖𝑖𝑘𝑘 + 𝜀𝜀𝑖𝑖                                                   (4) 
where α is the constant, β is the coefficient that measures the relationship between each 
explanatory factor (x) and the immunisation variable 𝑦𝑦𝑖𝑖 and 𝜀𝜀𝑖𝑖 is the error term (Wagstaff et al, 
2003). The concentration index (C) can also be written as  
                                                                       (5) 
where μ is the mean of the immunisation variable, 𝐶𝐶𝑘𝑘 is the concentration index of the kth 
contributing factor, GCԑ is generalised concentration index from the error term. The first term 
in equation (5) (𝛽𝛽𝑘𝑘?̅?𝑥𝑘𝑘/𝜇𝜇)  represents the elasticity of immunisation variable to marginal 
changes in the kth factor.  When multiplied by 𝐶𝐶𝑘𝑘 it provides the contributions of the kth factor 
to the overall concentration index (C).  The last part �𝐺𝐺𝐺𝐺𝜀𝜀
𝜇𝜇
� captures the residual, which 
represents the socioeconomic inequality that cannot be explained across SES groups by 
variations in the contributing factors. 
The variables (i.e. the kth contributing factor) used in the study were common variables of 
interest that have been identified in other research papers that include dummy variable of the 
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provinces to pick up regional fixed effects, mothers education, location of residence, quintiles 
and age of the child 
Stata version 14 was used to perform all statistical analyses. The Human Research Ethics 
Committee (HREC) of the Faculty of Health Sciences, University of Cape Town, has approved 
this research. 
 
Empirical results  
About 69% of children in Zimbabwe aged 12-59 month were fully immunised, 21% were 
partially immunised, and 10% did not receive any vaccination dose  
 
(Figure 1). Trend in immunisation coverage in Zimbabwe  
 
 
The concentration indices shown in Table 1 indicate that children who are not immunised are 
concentrated more among the lower SES groups because the concentration index is negative (-
0.0806). This result means the children from poorer families are most likely not to receive any 




fully immunised Partially immunised Not immunised
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Partially immunised children show a pro-poor relationship. Partially immunised children are 
concentrated among the poorer families with a negative concentration index (-0.0896), which 
is significant at the 1% significance level. Erreygers’ normalisation index (Ec) was estimated 
at -0.0413 which showed less inequality compared to the indirectly standardised concentration 
index. Full immunisation and immunisation intensity are pro-rich, with positive concentration 
indices estimated at 0.0250 and 0.0154, respectively and concentrated among the higher SES 
groups.  
The concentration curves from Figure 2 also show that no immunisation and partial 
immunisation are concentrated among the poor because the concentration curves lie above the 
line if equity, and full immunisation and immunisation intensity are concentrated among the 
richer families because the curves lie below the line of equity. 
 






concentration index  
Wc Ec 
    
Not immunised  -0.0778 (0.0559) - 0.0806 (0.0468) ** -0.0878 (0.0559) -0.0355 (0.0059) 
*Partially 
immunised  -0.0878 (0.0165) ** - 0.0896 (0.0140) ** -0.0995 (0.0165) ** 
 
 
-0.0413 (0.0165) ** 
*Fully immunised  0.0250 (0.0010) * 
 
  0.0257 (0.0007) * 0.1079 (0.0010) * 0.0768 (0.0010) * 
 
*Immunisation 
intensity 0.0154 (0.0055) * 
   
 
   0.0158 (0.0044) *     
Notes: Wc, Wagstaff’s normalisation of indirectly standardised concentration index, Ec, Erreygers normalisation of indirectly 








   
 
Table 2: Decomposition results for immunisation coverage in Zimbabwe, 2015 
  
 
                       
Immunisation 
Intensity  
    
Elasticity  Concentration 
index  
Contribution  Percentage 
contribution     
Age  
 
-0.07089 0.00644 -0.00046 -3% 
Female  
 
0.00714 0.02094 0.00015 1% 
Urban  
 
-0.01858 0.64941 -0.01207 -78% 
Mother's education  0.03227 0.16998 0.00549 36% 
Mother's age  0.06797 0.00187 0.00013 1% 
Quintiles  
   
0.01861 121% 




    
Residual        0.00067 4% 
      
A negative (positive) contribution of an explanatory factor to the C for child vaccination 
suggests that socioeconomic distribution of the explanatory factor (the Ck) and the relationship 
between the relevant explanatory factor and child vaccination status contributes to a higher 
probability of child vaccination uptake among the poor (rich) (Hajizadeh, 2019) 
The decomposition analysis was based on immunisation intensity. It had some significant 
contributors to inequality which included SES, mother’s education, provinces fixed effect, and 
place of residence (rural/urban). The quintiles (SES) showed the most significant contribution 
to inequality (121%) showing that people from higher socioeconomic statuses are more likely 
to have their children immunised compared to those from lower socioeconomic status levels. 
Mother’s education has a positive elasticity (0.03227) and a positive percentage contribution 
(36%) meaning that children with parents with a higher education are more likely to get 
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immunised. Place of residence plays a crucial role according to the decomposition analysis as 
to the chances of a child getting immunised. The negative contribution of the urban variable 
means that children in urban areas are less likely to be fully immunised compared to children 
in rural areas. Proximity to health facilities differs between rural and urban areas, where people 
in rural areas usually travel longer distances to access a health facility. Overall, the desired full 
immunisation coverage is concentrated among the high SES groups which need to be 
addressed. 
Discussion  
This article revealed that full immunisation and immunisation intensity were concentrated 
among the rich. Children who were not immunised and those with partial immunisation were 
concentrated among the poor. This goes hand in hand with the health gradient where higher 
immunisation would be associated with a higher SES (Deaton, 2002). 
Immunisation of children is a very important intervention that has averted diseases like 
smallpox, polio and measles in some countries like Nigeria (Ataguba et al, 2016). The results 
of this paper are consistent with most findings elsewhere, supporting the social gradient 
phenomenon. Social gradient explains that poorer people are more likely to be ill as reflected 
in the results of this paper (Donkin, 2014). We find that children from poorer families are less 
likely to be fully immunised. Full immunisation coverage is consistently higher among the rich 
and those living in urban areas. Unimmunised children are a small portion but they are mainly 
concentrated among the poor households. All children deserve a fair chance to receive all doses 
of immunisation that they need to make sure they have a chance to live a full life. As has been 
discussed, immunisation averts a lot of deaths making the topic of immunisation coverage 
important. SES is a starting point to an array of problems seen in countries creating a starting 
point for governments to address a range of issues. 
The decomposition analysis showed that variables like mother’s education, SES, and place of 
residence have positive contributions to inequality. Knowledge of these variables should be 
able to assist the government regarding specific areas that they should be concentrating on such 
that children have a better chance of living past the age of 5 years.  
Mother’s education is an important variable, especially in developing countries. It also reflects 
the patriarchal systems in place (Watson, 1990).  Mother’s education is a very important 
variable that contributes highly after SES in a lot of studies that have been conducted in 
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countries like Nigeria, India and Iran (Ataguba et al, 2016; Hosseinpoor et al, 2006; Khan et 
al, 2017; Lauridsen & Pradhan, 2011). Abuya (Abuya et al, 2011) had results from Kenya that 
showed that children born to mothers who had a primary education were 2.17 more times likely 
to be vaccinated than children whose mothers had no formal education. Mothers who have 
higher education are more likely to have their children vaccinated. Grépin & Bharadwaj (2005) 
noted in a study in Zimbabwe that an additional year in school for mothers was associated with 
a 21% decline in mortality. A strong focus to increase educational levels among women who 
will become mothers is important, as well as to make sure that mothers are educated on the 
importance of having their children live longer lives, through different methods such as fliers, 
health talks at health facilities, and media. 
Another important factor contributing to socioeconomic inequality is the place of residence. 
Children residing in urban areas are more likely to be immunised than those in rural areas. 
Some access barriers are usually associated with rural health facilities, which include 
proximity, acceptability and indirect costs (Chung et al, 2016). Other studies also report low 
immunisation coverage for people in rural communities (Ataguba et al, 2016; Hosseinpoor et 
al, 2006). Namibia was an odd case from similar studies where children who were not 
immunised were more concentrated in ‘urban’ locations. This  was due to an increase in slums 
associated with rural-urban migration (Crocker-Buque et al, 2017). Supply-side factors such as 
incentives to get children immunised can be improved in rural areas and slums (Banerjee et al, 
2010).  
Different provinces adopt health policies differently, and it is reflected in how they offer health 
services in different health facilities. Under-5 mortality rates among provinces range from 50 
deaths out of 1000 births in Bulawayo, to 112 deaths out 1000 births in Manicaland. Different 
provinces have different religions and cultures which could attribute to how people accept 
health services, including getting their children immunised. Mukungwa (Mukungwa, 2015) 
notes that a province such as Manicaland has the highest concentration of the Johanne Marange 
religion that opposes healthcare but rely on prophetic healing, which could be the reason for 
the high mortality rates in that province. In Northern Nigeria, polio immunisation is low due to 
lack of trust in the government and the immunisations themselves (Ataguba et al, 2016). 
Previous studies looking at a socioeconomic inequality concentrating on immunisation 
coverage have concluded that children from lower SES groups are less likely to get fully 
immunised (Donfouet et al, 2019; Hajizadeh, 2018; Lauridsen & Pradhan, 2011).  
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In Zimbabwe and Africa in general, there is an increasing need to cater to the health needs of 
the poorest members of society. More broadly, the indictment of the effects of the current 
political, social and economic conditions of the Zimbabwean government on population health 
is clear (Kevany et al, 2012). In particular, the inability of the Zimbabwean government to 
provide even the most basic forms of public health services to its citizens means that those in 
need are increasingly limited to more expensive private-sector providers, which they can ill-
afford (Kevany et al, 2012). Because the private sector is perceived to have better service, 
people are sometimes forced to seek private health services where out-of-pocket payment plans 
are most common (Kwesiga et al, 2015)  
The study has some strengths that are shown by immunisation categorisation. People will have 
different reasons for the different categories, and it is important to know why some caregivers 
do not get their children immunised. An extra category of immunisation intensity was added. 
Knowing the factors that account for full immunisation are essential so that the government 
can further invest in them. This article does not merely provide an estimate of socioeconomic 
inequality but goes further to explain factors that underlie the disparities, which is essential for 
policy formulation. The most important thing is for the government to know what affects full 
immunisation coverage and be able to deal with the issues so that immunisation coverage can 
be increased and eliminate vaccine-preventable diseases and deaths. A challenge faced in the 
analysis is data availability and not calculating standard errors. Some information from the 
survey was self-reported which may over or underestimate the number of vaccines received 
Recommendations  
The government of Zimbabwe has to get to a point where it does not rely heavily on donor 
funding to try and try raise funds internally, just like how Thailand has managed to take control 
of its health sector. However, this requires the economy to be functioning normally as well 
(Yiengprugsawan et al, 2010). 
Poor governance is a serious issue in Zimbabwe, and there is a general lack of transparency in 
a lot of the things that happen (Cain, 2016). Rural areas usually have a significant proportion 
of partially immunised children because of issues like access barriers. In knowing this, the 
government would need to build more health facilities within a certain radius to allow people 
to access health services without having problems (Ray & Masuka, 2017). 
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Measles and cholera are outbreaks that Zimbabwe has recently faced exposing the poor 
infrastructure that the country has such as cracked sewers, water shortages etc. The country's 
weak health system urgently needs to be revived (Mihigo et al, 2017). Inadequate funding of 
the health sector will likely affect other projects if money is directed towards fighting 
outbreaks. 
Traditional healers are a common destination for a lot of people and a good way to regulate 
some of the things they have people doing is to incorporate them into the formal health system 
network. This way, they are accountable when they give bad advice to people. 
 
Conclusions  
Reducing child mortality has been recognised to be essential, therefore it is important for 
Zimbabwe to improve immunisation coverage after understanding the different factors that 
affect poor people especially from getting their children immunised. Mothers’ education, place 
and province of residence and SES are key factors in immunisation coverage, which means 
these are areas that need to be improved and reduce the disparities that are in the country.  
Local context adoption of health policies between different provinces can improve acceptance 
of immunisation services within communities depending on how the Ministry of Health 
educates people in regards to the importance of certain practices such as uptake of 
immunisation services. 
The high disease burden that the country faces should be taken into account when tackling all 
these public health. There could be children who have other diseases that may adverse reactions 
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Addressing disparities in immunisation coverage 









   
INTRODUCTION 
 
Child mortality is a global issue that has been receiving a lot of attention. Under 5 mortality 
rates have improved globally with children less likely to die before the age of 5 years currently, 
as compared to the 1990s. Sub-Saharan Africa region still has the highest mortality rates and 
lowest rates of immunisation coverage.  In Africa, children are 15 times more likely to die 
before they reach the age of 5 years. Even in Africa, there are disparities in under 5 mortality 
rates between countries and sub-regions. 
Internationally, disparities in immunisation coverage between the poor and the rich continue to 
raise a concern for policymakers. Poor people are usually unable to get their children fully 
immunised as opposed to their rich counterparts. Low-income countries experience more 
disparities. 
The Zimbabwean government introduced the Expanded Program on Immunisation in 1981 to 
avert child deaths from 6 vaccine-preventable diseases: measles, tuberculosis, pertussis 
(whooping cough), diphtheria, tetanus and poliomyelitis. However, the country’s challenging 
economic conditions have affected immunisation coverage rates, especially in recent times.  
Data show that full immunisation coverage rate reduced to 89% in 2018 from 91% in 2016. 
    Key Messages  
• Full immunisation is in favour of the rich than the poor.  
• Children from well of families are more likely to be fully immunised as 




The health system is challenged by poor infrastructure such a scracked sewers shown by the 
typhoid and cholera outbreaks experienced. There is a lack of internal funding and a heavy 
reliance on donor funding, making it difficult to address key health-related issues including 
ensuring adequate immunisation coverage for children in Zimbabwe. 
Zimbabwe’s infant mortality rate was estimated at 36 deaths per 1000 live births and under 5 
mortality rate was 69 deaths per 1000 live births in 2017. HIV and AIDS have contributed to 
21% of child deaths. In efforts to reduce mortality rates and increase health service utilisation 
for poor and needy, the country abolished user fees in 2017. While this was welcomed, the free 
vaccine services did not address other major access barriers, especially for those in rural areas.  
 
Access barriers such as long distances to reach 
health facilities, attitudes of staff at health 
facilities, drug stock outs and indirect costs such 
as transport costs and food costs remain. All 
these factors are issues that need to be addressed 
by governments to help improve immunisation 
coverage in Zimbabwe. Addressing these 
barriers in addition to removing user fees will 
enable all groups especially the marginalised to receive immunisation services for their 
children. 
The aim of the paper was to explain the factors that contribute to disparities in immunisation 
coverage. Better knowledge of these factors could help improve utilisation of immunisation 
services.  
 
Approach to analysis  
 





In 2015 69% of children were fully immunised, 21% were partially immunised and 10% did 










In the analysis immunisation was grouped into four categories namely: fully immunised 
(having received 10 doses), partially immunised (having received between 1 and 9 doses), not 
immunised (not having received any dose) and immunisation intensity (proportion of doses 
received over the 10 doses that should be received). The analysis assessed disparities between 













FIG 1.TREND IN IMMUNISATION COVERAGE IN 
ZIMBABWE
Box 1: Zimbabwe immunisation schedule for children under 12 month 
First contact at birth – BCG 
Second contact at 6 weeks – OPV 1, DTP-HepB-Hib1 (Pentavalent), PCV 
Third contact at 10 weeks – OPV 2, DTP-Hep B-Hib 2 (Pentavalent), PCV 2 







Table 1: Who gets immunised in Zimbabwe?  The rich or the poor? 
Category of immunisation                   Who gets immunised?  
Full immunisation                                Predominantly the rich  
Partial immunisation                           Predominantly the poor  
No immunisation                                  Predominantly the poor 
Immunisation intensity                        The rich receive more immunisation than the poor 
  
Children belonging to poorer households are less likely to be fully immunised as opposed to 
children from richer households.  
Certain variables contribute to the disparities in immunisation coverage in Zimbabwe. The less 
education a mother attains, the less likely they will have their child fully immunised. Location 
of residence (urban/rural) is also important. Children residing in urban areas are more likely to 
receive full immunisation compared to children in rural areas. Proximity to health facilities 
differs depending on the location of residence. People in rural areas travel longer distances to 
health facilities than those in urban areas. The province of residence also contributes to chances 
of immunisation occurring because different provinces adopt policies differently. Generally, 
full immunisation is concentrated among the wealthier groups in society.  
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 Policy recommendations (long term)  
 
o Find methods to improve internal 
funding within the country, relying less on 
donor funding.  
 
o Ensuring that vaccines are made 
available to all Zimbabweans  services by 
outreach services 
 
o Government to build more health 
facilities in closer proximity to peoples’ homes, especially for the rural 
population so that they do not incur access barriers   
 
 
Support and Funding  
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Online articles Huynen MMTE, Martens P, Hilderlink HBM. The health impacts of globalisation: a conceptual 
framework. Global Health. 2005;1: 14. Available 
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newspapers and 
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The New York Times. 2014 Jan 29 [Cited 2014 March 17]. Available 
from: http://www.nytimes.com/2014/01/30/science/earth/climate-change-taking-toll-on-
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Supporting information 
Authors can submit essential supporting files and multimedia files along with their manuscripts. All supporting 
information will be subject to peer review. All file types can be submitted, but files must be smaller than 20 MB 
in size. 
Authors may use almost any description as the item name for a supporting information file as long as it contains 
an “S” and number. For example, “S1 Appendix” and “S2 Appendix,” “S1 Table” and “S2 Table,” and so 
forth.   
Supporting information files are published exactly as provided, and are not copyedited. 
Supporting information captions 
List supporting information captions at the end of the manuscript file. Do not submit captions in a separate file. 
The file number and name are required in a caption, and we highly recommend including a one-line title as well. 





S1 Text. Title is strongly recommended. Legend is optional. 
In-text citations 
We recommend that you cite supporting information in the manuscript text, but this is not a requirement. If you 
cite supporting information in the text, citations do not need to be in numerical order. 
Read the supporting information guidelines for more details about submitting supporting information 
and multimedia files. 
Figures and tables 
Figures 
Do not include figures in the main manuscript file. Each figure must be prepared and submitted as an individual 
file. 
Cite figures in ascending numeric order at first appearance in the manuscript file. 
Read the guidelines for figures and requirements for reporting blot and gel results. 
Figure captions 
Figure captions must be inserted in the text of the manuscript, immediately following the paragraph in which the 
figure is first cited (read order). Do not include captions as part of the figure files themselves or submit them in 
a separate document. 
At a minimum, include the following in your figure captions: 
• A figure label with Arabic numerals, and “Figure” abbreviated to “Fig” (e.g. Fig 1, Fig 2, 
Fig 3, etc). Match the label of your figure with the name of the file uploaded at submission 
(e.g. a figure citation of “Fig 1” must refer to a figure file named “Fig1.tif”). 
• A concise, descriptive title 
The caption may also include a legend as needed. 




Cite tables in ascending numeric order upon first appearance in the manuscript file. 
Place each table in your manuscript file directly after the paragraph in which it is first cited (read order). Do not 
submit your tables in separate files. 
Tables require a label (e.g., “Table 1”) and brief descriptive title to be placed above the table. Place legends, 
footnotes, and other text below the table.  
Statistical reporting 
Manuscripts submitted to PLOS ONE are expected to report statistical methods in sufficient detail for others to 
replicate the analysis performed. Ensure that results are rigorously reported in accordance with community 
standards and that the statistical methods employed are appropriate for the study design. 
Reporting of statistical methods 
In the methods, include a section on statistical analysis that reports a detailed description of the statistical 
methods. In this section: 
• List the name and version of any software package used, alongside any relevant references 
• Describe the technical details or procedures required to reproduce the analysis 
• Provide the repository identifier for any code used in the analysis (See our code-sharing 
policy.) 
Statistical reporting guidelines: 
• Identify research design and independent variables as being between- or within-subjects 
• For pre-processed data: 
o Describe any analysis carried out to confirm the data meets the assumptions of the 
analysis performed (e.g. linearity, co-linearity, normality of the distribution). 
o If data were transformed include this information, with a reason for doing so and a 
description of the transformation performed 
• Provide details of how outliers were treated and your analysis, both with the full dataset and 
with the outliers removed 
• If relevant, describe how missing/excluded data were handled 
• Define the threshold for significance (alpha) 
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• If appropriate, provide sample sizes, along with a description of how they were determined. If 
a sample size calculation was performed, specify the inputs for power, effect size and alpha. 
Where relevant, report the number of independent replications for each experiment. 
• For analyses of variance (ANOVAs), detail any post hoc tests that were performed 
• Include details of any corrections applied to account for multiple comparisons. If corrections 
were not applied, include a justification for not doing so 
• Describe all options for statistical procedures. For example, if t-tests were performed, state 
whether these were one- or two-tailed. Include details of the type of t-test conducted (e.g. one 
sample, within-/between-subjects). 
• For step-wise multiple regression analyses: 
o Report the alpha level used 
o Discuss whether the variables were assessed for collinearity and interaction 
o Describe the variable selection process by which the final model was developed (e.g., 
forward-stepwise; best subset). See SAMPL guidelines. 
• For Bayesian analysis explain the choice of prior trial probabilities and how they were 
selected. Markov chain Monte Carlo settings should be reported. 
Reporting of statistical results 
Results must be rigorously and appropriately reported, in keeping with community standards. 
• Units of measurement. Clearly define measurement units in all tables and figures. 
• Properties of distribution. It should be clear from the text which measures of variance 
(standard deviation, standard error of the mean, confidence intervals) and central tendency 
(mean, median) are being presented. 
• Regression analyses. Include the full results of any regression analysis performed as a 
supplementary file. Include all estimated regression coefficients, their standard error, p-
values, and confidence intervals, as well as the measures of goodness of fit. 
• Reporting parameters. Test statistics (F/t/r) and associated degrees of freedom should be 
provided. Effect sizes and confidence intervals should be reported where appropriate. If 
percentages are provided, the numerator and denominator should also be given. 
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• P-values. Report exact p-values for all values greater than or equal to 0.001. P-values less 
than 0.001 may be expressed as p < 0.001, or as exponentials in studies of genetic 
associations. 
• Displaying data in plots. Format plots so that they accurately depict the sample distribution. 
3D effects in plots can bias and hinder interpretation of values, so avoid them in cases where 
regular plots are sufficient to display the data. 
• Open data. As explained in PLOS’s Data Policy, be sure to make individual data points, 
underlying graphs and summary statistics available at the time of publication. Data can be 
deposited in a repository or included within the Supporting Information files. 
Data reporting 
All data and related metadata underlying the findings reported in a submitted manuscript should be deposited in 
an appropriate public repository, unless already provided as part of the submitted article. 
See instructions on providing underlying data to support blot and gel results 
Repositories may be either subject-specific (where these exist) and accept specific types of structured data, or 
generalist repositories that accept multiple data types. We recommend that authors select repositories 
appropriate to their field. Repositories may be subject-specific (e.g., GenBank for sequences and PDB for 
structures), general, or institutional, as long as DOIs or accession numbers are provided and the data are at least 
as open as CC BY. Authors are encouraged to select repositories that meet accepted criteria as trustworthy 
digital repositories, such as criteria of the Centre for Research Libraries or Data Seal of Approval. Large, 
international databases are more likely to persist than small, local ones. 
To support data sharing and author compliance of the PLOS data policy, we have integrated our submission 
process with a select set of data repositories. The list is neither representative nor exhaustive of the suitable 
repositories available to authors. Current repository integration partners 
include Dryad and FlowRepository. Please contact data@plos.org to make recommendations for further 
partnerships. 
Instructions for PLOS submissions with data deposited in an integration partner repository: 
• Deposit data in the integrated repository of choice. 
• Once deposition is final and complete, the repository will provide you with a dataset DOI 
(provisional) and private URL for reviewers to gain access to the data. 
• Enter the given data DOI into the full Data Availability Statement, which is requested in the 
Additional Information section of the PLOS submission form. Then provide the URL 
passcode in the Attach Files section. 
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If you have any questions, please email us. 
Accession numbers 
All appropriate data sets, images, and information should be deposited in an appropriate public repository. See 
our list of recommended repositories. 
Accession numbers (and version numbers, if appropriate) should be provided in the Data Availability Statement. 
Accession numbers or a citation to the DOI should also be provided when the data set is mentioned within the 
manuscript. 
In some cases authors may not be able to obtain accession numbers of DOIs until the manuscript is accepted; in 
these cases, the authors must provide these numbers at acceptance. In all other cases, these numbers must be 
provided at full submission. 
Identifiers 
As much as possible, please provide accession numbers or identifiers for all entities such as genes, proteins, 
mutants, diseases, etc., for which there is an entry in a public database, for example: 
• Ensembl 
• Entrez Gene 
• FlyBase 
• InterPro 
• Mouse Genome Database (MGD) 
• Online Mendelian Inheritance in Man (OMIM) 
• PubChem 
Identifiers should be provided in parentheses after the entity on first use. 
Striking image 
You can choose to upload a “Striking Image” that we may use to represent your article online in places like the 
journal homepage or in search results. 
The striking image must be derived from a figure or supporting information file from the submission, i.e., a 
cropped portion of an image or the entire image. Striking images should ideally be high resolution, eye-catching, 
single panel images, and should ideally avoid containing added details such as text, scale bars, and arrows. 
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If no striking image is uploaded, we will designate a figure from the submission as the striking image. 
Striking images should not contain potentially identifying images of people.  Read our policy on 
identifying information. 
 
The PLOS licenses and copyright policy also applies to striking images. 
Additional Information Requested at Submission 
Financial Disclosure Statement 
This information should describe sources of funding that have supported the work. It is important to gather these 
details prior to submission because your financial disclosure statement cannot be changed after initial 
submission without journal approval. If your manuscript is published, your statement will appear in the 
Funding section of the article. 
Enter this statement in the Financial Disclosure section of the submission form. Do not include it in your 
manuscript file. 
The statement should include: 
• Specific grant numbers 
• Initials of authors who received each award 
• Full names of commercial companies that funded the study or authors 
• Initials of authors who received salary or other funding from commercial companies 
• URLs to sponsors’ websites 
Also state whether any sponsors or funders (other than the named authors) played any role in: 
• Study design 
• Data collection and analysis 
• Decision to publish 
• Preparation of the manuscript 
If they had no role in the research, include this sentence: “The funders had no role in study design, data 
collection and analysis, decision to publish, or preparation of the manuscript.” 
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If the study was unfunded, include this sentence as the Financial Disclosure statement: “The author(s) received 
no specific funding for this work." 
Read our policy on disclosure of funding sources. 
Competing interests 
This information should not be in your manuscript file; you will provide it via our submission system. 
All potential competing interests must be declared in full. If the submission is related to any patents, patent 
applications, or products in development or for market, these details, including patent numbers and titles, must 
be disclosed in full. 
Read our policy on competing interests. 
Manuscripts disputing published work 
For manuscripts disputing previously published work, it is PLOS ONE policy to invite a signed review by the 
disputed author during the peer review process. This procedure is aimed at ensuring a thorough, transparent, and 
productive review process. 
If the disputed author chooses to submit a review, it must be returned in a timely fashion and contain a full 
declaration of all competing interests. The Academic Editor will consider any such reviews in light of the 
competing interest. 
Authors submitting manuscripts disputing previous work should explain the relationship between the 
manuscripts in their cover letter, and will be required to confirm that they accept the conditions of this review 
policy before the manuscript is considered further. 
Related manuscripts 
Upon submission, authors must confirm that the manuscript, or any related manuscript, is not currently under 
consideration or accepted elsewhere. If related work has been submitted to PLOS ONE or elsewhere, authors 
must include a copy with the submitted article. Reviewers will be asked to comment on the overlap between 
related submissions. 
We strongly discourage the unnecessary division of related work into separate manuscripts, and we will not 
consider manuscripts that are divided into “parts.” Each submission to PLOS ONE must be written as an 
independent unit and should not rely on any work that has not already been accepted for publication. If related 
manuscripts are submitted to PLOS ONE, the authors may be advised to combine them into a single manuscript 
at the editor's discretion. 
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authors who wish to share their work early and receive feedback before formal peer review. Deposition of 
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